1 |
KEGG |
Cell adhesion molecules (CAMs) |
6.94 |
132 |
11 |
126 |
2.099 |
8.333 |
9.69E-04 |
2 |
KEGG |
Axon guidance |
6.94 |
130 |
11 |
126 |
2.099 |
8.462 |
9.69E-04 |
3 |
KEGG |
Leukocyte transendothelial migration |
5.288 |
117 |
9 |
113 |
1.718 |
7.692 |
0.005054 |
4 |
KEGG |
Type I diabetes mellitus |
5.232 |
44 |
5 |
40 |
0.954 |
11.364 |
0.005344 |
5 |
KEGG |
Regulation of actin cytoskeleton |
4.461 |
206 |
12 |
198 |
2.29 |
5.825 |
0.011556 |
6 |
KEGG |
Natural killer cell mediated cytotoxicity |
4.11 |
128 |
8 |
114 |
1.527 |
6.25 |
0.016401 |
7 |
KEGG |
Focal adhesion |
3.949 |
194 |
11 |
188 |
2.099 |
5.67 |
0.019276 |
8 |
KEGG |
Tight junction |
3.187 |
119 |
7 |
112 |
1.336 |
5.882 |
0.041314 |
9 |
KEGG |
Antigen processing and presentation |
3.112 |
86 |
5 |
68 |
0.954 |
5.814 |
0.044499 |
10 |
KEGG |
Adherens junction |
2.721 |
77 |
5 |
76 |
0.954 |
6.494 |
0.065823 |
11 |
KEGG |
Colorectal cancer |
2.676 |
77 |
5 |
77 |
0.954 |
6.494 |
0.068828 |
12 |
KEGG |
Circadian rhythm |
2.386 |
18 |
2 |
18 |
0.382 |
11.111 |
0.091979 |
13 |
KEGG |
Maturity onset diabetes of the young |
1.975 |
25 |
2 |
23 |
0.382 |
8 |
0.138816 |
14 |
KEGG |
VEGF signaling pathway |
1.972 |
72 |
4 |
70 |
0.763 |
5.556 |
0.139208 |
15 |
KEGG |
Fc epsilon RI signaling pathway |
1.83 |
75 |
4 |
74 |
0.763 |
5.333 |
0.160493 |
16 |
KEGG |
mTOR signaling pathway |
1.811 |
49 |
3 |
49 |
0.573 |
6.122 |
0.16353 |
17 |
KEGG |
Huntington's disease |
1.558 |
30 |
2 |
30 |
0.382 |
6.667 |
0.210455 |
18 |
KEGG |
Wnt signaling pathway |
1.474 |
147 |
6 |
144 |
1.145 |
4.082 |
0.229071 |
19 |
KEGG |
MAPK signaling pathway |
1.441 |
273 |
10 |
268 |
1.908 |
3.663 |
0.236637 |
20 |
KEGG |
Toll-like receptor signaling pathway |
1.416 |
91 |
4 |
88 |
0.763 |
4.396 |
0.242667 |
21 |
KEGG |
B cell receptor signaling pathway |
1.318 |
63 |
3 |
63 |
0.573 |
4.762 |
0.267565 |
22 |
KEGG |
T cell receptor signaling pathway |
1.294 |
93 |
4 |
93 |
0.763 |
4.301 |
0.274064 |
23 |
KEGG |
Long-term potentiation |
1.235 |
67 |
3 |
66 |
0.573 |
4.478 |
0.290928 |
24 |
KEGG |
Insulin signaling pathway |
1.143 |
135 |
5 |
131 |
0.954 |
3.704 |
0.318761 |
25 |
KEGG |
Type II diabetes mellitus |
1.117 |
44 |
2 |
41 |
0.382 |
4.545 |
0.327167 |
26 |
KEGG |
Dentatorubropallidoluysian atrophy (DRPLA) |
1.044 |
15 |
1 |
15 |
0.191 |
6.667 |
0.352194 |
27 |
KEGG |
Epithelial cell signaling in Helicobacter pylori infection |
0.997 |
46 |
2 |
45 |
0.382 |
4.348 |
0.368822 |
28 |
KEGG |
Parkinson's disease |
0.992 |
16 |
1 |
16 |
0.191 |
6.25 |
0.370684 |
29 |
KEGG |
Cytokine-cytokine receptor interaction |
0.963 |
256 |
8 |
241 |
1.527 |
3.125 |
0.381922 |
30 |
KEGG |
Jak-STAT signaling pathway |
0.936 |
153 |
5 |
144 |
0.954 |
3.268 |
0.392344 |
31 |
KEGG |
Apoptosis |
0.86 |
84 |
3 |
83 |
0.573 |
3.571 |
0.423249 |
32 |
KEGG |
Complement and coagulation cascades |
0.6 |
69 |
2 |
64 |
0.382 |
2.899 |
0.548544 |
33 |
KEGG |
Olfactory transduction |
0.523 |
31 |
1 |
31 |
0.191 |
3.226 |
0.592482 |
34 |
KEGG |
SNARE interactions in vesicular transport |
0.468 |
36 |
1 |
34 |
0.191 |
2.778 |
0.62642 |
35 |
KEGG |
Phosphatidylinositol signaling system |
0.421 |
79 |
2 |
78 |
0.382 |
2.532 |
0.656227 |
36 |
KEGG |
Taste transduction |
0.317 |
53 |
1 |
45 |
0.191 |
1.887 |
0.728441 |
37 |
KEGG |
GnRH signaling pathway |
0.277 |
97 |
2 |
95 |
0.382 |
2.062 |
0.758254 |
38 |
KEGG |
Gap junction |
0.27 |
99 |
2 |
96 |
0.382 |
2.02 |
0.763352 |
39 |
KEGG |
Adipocytokine signaling pathway |
0.145 |
69 |
1 |
69 |
0.191 |
1.449 |
0.864684 |
40 |
KEGG |
Long-term depression |
0.124 |
75 |
1 |
74 |
0.191 |
1.333 |
0.882976 |
41 |
KEGG |
Neuroactive ligand-receptor interaction |
0.102 |
302 |
5 |
279 |
0.954 |
1.656 |
0.902917 |
42 |
KEGG |
ECM-receptor interaction |
0.086 |
87 |
1 |
86 |
0.191 |
1.149 |
0.91743 |
43 |
KEGG |
Cell cycle |
0.042 |
112 |
1 |
110 |
0.191 |
0.893 |
0.958921 |
44 |
KEGG |
Calcium signaling pathway |
0.041 |
176 |
2 |
173 |
0.382 |
1.136 |
0.959904 |